You can also collect from your local Superdrug pharmacy
Standard Dosing Ranges The most extensively studied dosing protocols for subcutaneous administration include: Research-Based Dosing Protocols Beginner/Conservative Protocol: Dose: 250-300 mcg once daily Duration: 4-8 weeks initial assessment period Rationale: Allows tolerance assessment and response evaluation at lower end of therapeutic range Standard Protocol: Dose: 300-500 mcg once daily Duration: 12-24 weeks based on clinical trials Rationale: Most commonly studied range in human research with optimal benefit-to-safety ratio Advanced Protocol: Dose: 500 mcg-1 mg once daily Duration: 12-24 weeks under close medical monitoring Rationale: Upper clinical range
For obese populations with comorbidities such as type 2 diabetes, heart failure, and obstructive sleep apnea, it holds extensive therapeutic value
Corneal conditions (dry eye, injuries, post-surgical) Mechanism: Various causes including inflammation (dry eye), trauma, infections, surgical complications, or neurotrophic issues (reduced corneal sensation impairing healing)
It is considered investigational, and human safety data is limited
Our vendor assessments cover options for both cagrilintide sources and retatrutide sources with emphasis on quality verification
